» Articles » PMID: 28616665

Psychoneurocutaneous Medicine: Past, Present and Future

Overview
Specialty General Medicine
Date 2017 Jun 16
PMID 28616665
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Psychoneurocutaneous medicine is an important and rapidly growing field. It is an integrative science created to address the interaction between the mind, nervous system and skin. Four major fields are involved: psychiatry, psychology, neurology and dermatology. The history of psychoneurocutaneous medicine is old and fascinating. Even though it is a young science only established in the last century, allusions to the nervous system and diseases of the skin can be traced back thousands of years in the literature. Characteristically, the last two centuries were of special importance for the development of this field in Europe, lately in America, with great effort placed on research and publications. More recently, the creation of associations, work groups and the merging of subspecialties dedicated exclusively to study the psychological impact of skin disorders in subpopulations of patients have helped to give momentum to psychoneurocutaneous medicine. Further development of this field will shed light on the appropriate diagnosis and treatment of psychodermatologic disorders, enhancing the functionality and quality of life of patients. This paper presents a summary of the most influential facts in the history of psychoneurocutaneous medicine, its present and future perspectives.

Citing Articles

Validation of a novel method of ultraviolet-induced cutaneous inflammation and its associations with anhedonia.

Sullivan-Toole H, Feng S, Carlton C, Ghane M, Olino T, Allen I Sci Rep. 2022; 12(1):20237.

PMID: 36424456 PMC: 9691739. DOI: 10.1038/s41598-022-24598-4.


Clinical Applications of System Regulation Medicine.

Fioranelli M, Sepehri A, Roccia M, Linda C, Rossi C, Dawodo A Open Access Maced J Med Sci. 2019; 7(18):3053-3060.

PMID: 31850122 PMC: 6910802. DOI: 10.3889/oamjms.2019.775.


Expressive Suppression and Negative Affect, Pathways of Emotional Dysregulation in Psoriasis Patients.

Ciuluvica C, Fulcheri M, Amerio P Front Psychol. 2019; 10:1907.

PMID: 31496974 PMC: 6712996. DOI: 10.3389/fpsyg.2019.01907.


Implementation of a psychodermatology clinic at a major health system in Detroit.

Seale L, Gaulding J, Porto D, Prabhakar D, Kerr H Int J Womens Dermatol. 2019; 4(4):227-229.

PMID: 30627622 PMC: 6322150. DOI: 10.1016/j.ijwd.2018.05.002.

References
1.
Bjornsson A, Didie E, Phillips K . Body dysmorphic disorder. Dialogues Clin Neurosci. 2010; 12(2):221-32. PMC: 3181960. View

2.
Franca K, Chacon A, Ledon J, Savas J, Nouri K . Pyschodermatology: a trip through history. An Bras Dermatol. 2013; 88(5):842-3. PMC: 3798372. DOI: 10.1590/abd1806-4841.20132059. View

3.
Ader R, Cohen N . Psychoneuroimmunology: conditioning and stress. Annu Rev Psychol. 1993; 44:53-85. DOI: 10.1146/annurev.ps.44.020193.000413. View

4.
Kiecolt-Glaser J, Glaser R . Psychoneuroimmunology and health consequences: data and shared mechanisms. Psychosom Med. 1995; 57(3):269-74. DOI: 10.1097/00006842-199505000-00008. View

5.
Koo J, Pham C . Psychodermatology. Practical guidelines on pharmacotherapy. Arch Dermatol. 1992; 128(3):381-8. DOI: 10.1001/archderm.128.3.381. View